Yam side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Arteriospasm coronary (spasm of the large- or medium-sized coronary arteries)
2. Arthralgia (joint pain)
3. Breast cancer
4. Impaired gastric emptying
5. Abdominal distension
6. Drug ineffective
7. Abdominal discomfort
8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
9. Abnormal dreams
10. Affective disorder (mental disorder)

male:

1. Abdominal pain
2. Anticoagulation drug level above therapeutic
3. Body mass index increased

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

1. Anticoagulation drug level above therapeutic
2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

50-59:

1. Anxiety
2. Arteriospasm coronary (spasm of the large- or medium-sized coronary arteries)
3. Arthralgia (joint pain)
4. Body mass index increased
5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
6. Impaired gastric emptying
7. Abdominal distension
8. Drug ineffective

60+:

1. Abdominal pain
2. Abdominal discomfort
3. Abnormal dreams

< 1 month:

n/a

1 - 6 months:

1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Abdominal distension
2. Arthralgia (joint pain)
3. Body mass index increased
4. Breast cancer
5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
6. Impaired gastric emptying
7. Abdominal pain
8. Drug ineffective
9. Abdominal discomfort
10. Abnormal dreams